radiology Archives - Medical Design Sourcing

Devices, disease, and digital: Holy Grail of healthcare AI

[Image courtesy of GE HealthCare]

In episode 3 of AI Meets Life Sci, DeviceTalks Managing Editor Kayleen Brown and Pharma and Biotech Editor Brian Buntz sit down with GE HealthCare Chief Digital Officer and GM of Oncology Ben Newton and Haley Schwartz of Catalyze Healthcare to discuss the impacts of AI to screen, diagnose, prognose, and treat cure disease while addressing real-world implementation issues from regulation and liability to clinician trust and adoption. They review the AI challenge of organizing disarrayed informational islands such as technology, clinical protocols, and digital solutions into cohesive, well-developed systems and offer insight into the medtech industry’s progress in this area.

Tune in and subscribe to AI Meets Life Sci on all major podcast channels and follow youtube.com/@DeviceTalks or AI Meets Life Sci YouTube Podcast to ensure you never miss an episode.

The AI Holy Grail for …

Devices, disease, and digital: Holy Grail of healthcare AI

[Image courtesy of GE HealthCare]

In episode 3 of AI Meets Life Sci, DeviceTalks Managing Editor Kayleen Brown and Pharma and Biotech Editor Brian Buntz sit down with GE HealthCare Chief Digital Officer and GM of Oncology Ben Newton and Haley Schwartz of Catalyze Healthcare to discuss the impacts of AI to screen, diagnose, prognose, and treat cure disease while addressing real-world implementation issues from regulation and liability to clinician trust and adoption.

They review the AI challenge of organizing disarrayed informational islands such as technology, clinical protocols, and digital solutions into cohesive, well-developed systems and offer insight into the medtech industry’s progress in this area.

The AI Holy Grail for decision support

Ben Newton

AI technologies emerged quickly over the last several years in medical imaging and oncology…

Radiology reimagined: Bayer and Google see AI as a win for practitioners and patients

AI is set to continue making inroads in radiology in the coming years, according to two executives from Bayer and Google.

In an interview at Google Cloud Next, Bayer’s Guido Mathews and Google Cloud’s Shweta Maniar highlighted the transformative influence of the technology on the radiologist’s workflow, the increasing integration of AI into radiological education, and its potential to mitigate burnout and reduce error rates.

Bayer offers contrast agents and injectors for major radiology modalities, including CT, MRI, an angiography.

In addition to focusing on radiology, Bayer Pharmaceuticals is using generative AI models like Google Cloud’s Vertex AI and Med-PaLM 2 to streamline drug development. Bayer is also using Google’s high-performance computing resources for quantum chemistry calculations.

AI’s radiological reboot

In 2016, deep learning pioneer Geoffrey Hinton predicted that AI systems would outperform radiologists by 2021…